• Dovitinib in RTK Assays: Workflow and Optimization

  2026-09-18

  Dovitinib (TKI-258) provides a practical way to probe convergent FLT3, c-Kit, FGFR, VEGFR, and PDGFR signaling in cancer models. This workflow pairs target-proximal phospho-readouts with apoptosis assays and uses chamber-specific cardiomyocyte research to sharpen model selection without overstating cross-domain evidence.

• Hypoxia, Immunometabolism, and Tumor Immune Escape

  2026-09-17

  This review frames tumor hypoxia and immunometabolism as a coupled system that links oxygen limitation, nutrient competition, immune dysfunction, and malignant progression. Its main practical contribution is a mechanistic framework for designing therapies that address both tumor-intrinsic metabolism and the immunosuppressive tumor microenvironment.

• ABT-888 (Veliparib): Biomarker-Aware PARP Studies

  2026-09-17

  ABT-888 (Veliparib) is a selective PARP1/2 inhibitor for mechanistic DNA repair inhibition studies. This article develops a biomarker-aware framework linking PARP assays with replication-stress biology, combination models, and the PPP2R2A–CHK1 findings in ovarian cancer research.

• ω-Agatoxin IVA TFA: Cav2.1 Blockade

  2026-09-16

  ω-Agatoxin IVA TFA is a selective P/Q-type Cav2.1 calcium-channel blocker used in neuronal calcium current recording, synaptic transmission research, and epilepsy animal model studies. Its potency depends on the Cav2.1 channel phenotype, so experimental interpretation must distinguish high-affinity P-type blockade from weaker Q-type and N-type effects.

• GS967 and the Aging Heart: Late INa as a Bridge

  2026-09-16

  GS967 offers a mechanistic route from pathological late sodium influx to ventricular repolarization, calcium handling, impaired relaxation, and arrhythmia. This article translates Nav1.5 Ser571 biology into practical electrophysiology, isolated-heart, aging, and ischemia-focused research strategies.

• L. plantarum P101, AMPK, and Alcoholic Steatosis

  2026-09-15

  A 2025 mouse study found that Lactiplantibacillus plantarum P101 reduced alcohol-induced hepatic lipid accumulation while activating AMPK. Pharmacological AMPK inhibition, gut microbiota profiling, and serum metabolomics together linked the probiotic response to AMPK-associated gut–liver metabolic changes.

• PAD4-IN-2 TFA: A Spatial Biology Guide

  2026-09-15

  PAD4-IN-2 TFA, also known as Compound 5i TFA, is best understood as a spatially selective probe of PAD4 biology rather than a conventional cytotoxic agent. This guide explains how its tumor uptake, histone H3 citrullination effects, NET suppression, and immune remodeling should shape experimental design and interpretation.

• Nile Red as a Quantitative Lipid Phenotyping Tool

  2026-09-14

  Nile Red enables dual-channel visualization of lipid droplets and membranes, but its greatest value comes from disciplined interpretation. This article develops a phenotype-first framework linking Nile Red imaging with autophagy and lipid metabolism research without confusing storage measurements with flux.

• Lipidated Nanophotosensitizer Disables Tumor EVs

  2026-09-14

  The reference study introduces a palmitic-acid-displayed nanophotosensitizer that both traces tumor extracellular vesicles (TEVs) and generates reactive oxygen species within tumor cells and TEVs. In female mouse models, this dual spatial activity suppressed primary tumors while disrupting TEV-mediated communication associated with metastasis.

• Recombinant Human Growth Hormone in IGF-1 Assays

  2026-09-13

  Build mechanism-driven chondrocyte and proliferation workflows with recombinant somatotropin, using controlled GH exposure to interrogate IGFBP2, THBS1, and IGF-1 signaling. This guide connects product specifications to practical assay design, controls, optimization, and troubleshooting for reproducible growth research.

• Tapuy Lees and Neuroprotection in C. elegans

  2026-09-12

  A 2025 study identifies Tapuy lees, a rice-wine fermentation by-product, as a stronger neuroprotective matrix than Tapuy wine in C. elegans models of amyloid-β toxicity and dopaminergic degeneration. Its combination of behavioral, neuronal, antioxidant, and LC–MS/MS analyses provides a useful framework for evaluating complex food-derived materials while underscoring the limits of extrapolating worm-model results to human disease.

• HPF in Copper Nanotherapy: Reading hROS Signals

  2026-09-12

  HPF (hydroxyphenyl fluorescein) provides selective green-fluorescence readouts of highly reactive oxygen species. This guide explains how to use HPF to distinguish radical chemistry from broader oxidative stress and cuproptosis-associated effects in copper nanotherapy assays.

• AZD8055: Practical mTOR Inhibition Workflow

  2026-09-11

  AZD8055 is an ATP-competitive mTOR inhibitor for controlled studies of mTORC1 and mTORC2 signaling, cancer cell proliferation, and metabolism. It is appropriate for mechanistic preclinical workflows, but its aqueous insolubility, formulation requirements, and limited clinical benefit mean that it should not be used as a substitute for clinical efficacy evidence.

• Dovitinib: From Kinome Breadth to Translational Insight

  2026-09-11

  Dovitinib (TKI-258, CHIR-258) is more than a broad RTK inhibitor: it can function as a mechanistic probe for linking receptor dependence, ERK and STAT signaling, apoptotic state, and tumor-model response. This article presents a translational framework for deploying its breadth deliberately, using cheminformatics-informed library logic, layered validation, and biomarker-aware experimental design.

• Nanoparticle Uptake in Human Corneal Epithelial Cells

  2026-09-10

  The reference study systematically examines how PLGA nanoparticle size and surface chemistry influence uptake by human corneal epithelial cells. Its in vitro evidence identifies energy-dependent endocytosis, particularly macropinocytosis and caveolae-mediated entry, as key mechanisms and provides design principles for more effective topical ocular delivery.

7942 records 1/530 page Next 12345 下5页 Last page